<?xml version='1.0' encoding='utf-8'?>
<document id="27001815"><sentence text="Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients."><entity charOffset="50-59" id="DDI-PubMed.27001815.s1.e0" text="Triazoles" /></sentence><sentence text="The majority of hospitalized patients receiving mold-active triazoles are at risk of drug-drug interactions (DDIs)"><entity charOffset="60-69" id="DDI-PubMed.27001815.s2.e0" text="triazoles" /></sentence><sentence text=" Efforts are needed to increase awareness of DDIs that pose a serious risk of adverse events" /><sentence text=" Triazoles remain the most commonly utilized antifungals"><entity charOffset="1-10" id="DDI-PubMed.27001815.s4.e0" text="Triazoles" /></sentence><sentence text=" Recent developments have included the mold-active triazoles (MATs) itraconazole, voriconazole, and posaconazole, which are first-line agents for the treatment of filamentous fungal infections but have the potential for DDIs"><entity charOffset="51-60" id="DDI-PubMed.27001815.s5.e0" text="triazoles" /><entity charOffset="68-80" id="DDI-PubMed.27001815.s5.e1" text="itraconazole" /><entity charOffset="82-94" id="DDI-PubMed.27001815.s5.e2" text="voriconazole" /><entity charOffset="100-112" id="DDI-PubMed.27001815.s5.e3" text="posaconazole" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e0" e2="DDI-PubMed.27001815.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e0" e2="DDI-PubMed.27001815.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e0" e2="DDI-PubMed.27001815.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e0" e2="DDI-PubMed.27001815.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e1" e2="DDI-PubMed.27001815.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e1" e2="DDI-PubMed.27001815.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e1" e2="DDI-PubMed.27001815.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e2" e2="DDI-PubMed.27001815.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s5.e2" e2="DDI-PubMed.27001815.s5.e3" /></sentence><sentence text=" This objective of this study was to evaluate the prevalence of triazole DDIs"><entity charOffset="64-72" id="DDI-PubMed.27001815.s6.e0" text="triazole" /></sentence><sentence text=" Hospitalized U" /><sentence text="S" /><sentence text=" adults with MAT use were identified in the Cerner HealthFacts database, which contained data from over 150 hospitals (2005 to 2013)" /><sentence text=" The severities of DDIs with MATs were categorized, using drug labels and the drug information from the Drugdex system (Thompson Micromedex), into four groups (contraindicated, major, moderate, and minor severity)" /><sentence text=" DDIs of minor severity were not counted" /><sentence text=" A DDI event was considered to have occurred if the following two conditions were met: (i) the patient used at least one drug with a classification of at least a moderate interaction with the MAT during the hospitalization and (ii) there was a period of overlap between the administration of the MAT and that of the interacting drug of at least 1 day" /><sentence text=" A total of 6,962 hospitalizations with MAT use were identified" /><sentence text=" Among them, 88% of hospitalizations with voriconazole use, 86% of hospitalizations with itraconazole use, and 93% of hospitalizations with posaconazole use included the use of a concomitant interacting drug"><entity charOffset="42-54" id="DDI-PubMed.27001815.s14.e0" text="voriconazole" /><entity charOffset="89-101" id="DDI-PubMed.27001815.s14.e1" text="itraconazole" /><entity charOffset="140-152" id="DDI-PubMed.27001815.s14.e2" text="posaconazole" /><pair ddi="false" e1="DDI-PubMed.27001815.s14.e0" e2="DDI-PubMed.27001815.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27001815.s14.e0" e2="DDI-PubMed.27001815.s14.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s14.e0" e2="DDI-PubMed.27001815.s14.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s14.e1" e2="DDI-PubMed.27001815.s14.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s14.e1" e2="DDI-PubMed.27001815.s14.e2" /></sentence><sentence text=" A total of 68% of hospitalizations with posaconazole use, 34% of hospitalizations with itraconazole use, and 20% of hospitalizations with voriconazole use included the use of at least one drug with a DDI of contraindicated severity"><entity charOffset="41-53" id="DDI-PubMed.27001815.s15.e0" text="posaconazole" /><entity charOffset="88-100" id="DDI-PubMed.27001815.s15.e1" text="itraconazole" /><entity charOffset="139-151" id="DDI-PubMed.27001815.s15.e2" text="voriconazole" /><pair ddi="false" e1="DDI-PubMed.27001815.s15.e0" e2="DDI-PubMed.27001815.s15.e0" /><pair ddi="false" e1="DDI-PubMed.27001815.s15.e0" e2="DDI-PubMed.27001815.s15.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s15.e0" e2="DDI-PubMed.27001815.s15.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s15.e1" e2="DDI-PubMed.27001815.s15.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s15.e1" e2="DDI-PubMed.27001815.s15.e2" /></sentence><sentence text=" A total of 83% of hospitalizations with posaconazole use, 61% of hospitalizations with itraconazole use, and 82% of hospitalizations with voriconazole use included the use of at least one drug that resulted in a severe DDI"><entity charOffset="41-53" id="DDI-PubMed.27001815.s16.e0" text="posaconazole" /><entity charOffset="88-100" id="DDI-PubMed.27001815.s16.e1" text="itraconazole" /><entity charOffset="139-151" id="DDI-PubMed.27001815.s16.e2" text="voriconazole" /><pair ddi="false" e1="DDI-PubMed.27001815.s16.e0" e2="DDI-PubMed.27001815.s16.e0" /><pair ddi="false" e1="DDI-PubMed.27001815.s16.e0" e2="DDI-PubMed.27001815.s16.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s16.e0" e2="DDI-PubMed.27001815.s16.e2" /><pair ddi="false" e1="DDI-PubMed.27001815.s16.e1" e2="DDI-PubMed.27001815.s16.e1" /><pair ddi="false" e1="DDI-PubMed.27001815.s16.e1" e2="DDI-PubMed.27001815.s16.e2" /></sentence><sentence text=" The findings of this study demonstrate that a majority of hospitalized patients receiving MAT are at risk for severe drug-drug interactions and highlight the need for antifungal stewardship" /><sentence text="" /></document>